253.07
price down icon0.26%   -0.67
after-market After Hours: 253.07
loading

Alnylam Pharmaceuticals Inc Stock (ALNY) Forecast

The Alnylam Pharmaceuticals Inc (ALNY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $207.88, representing a -17.86% decrease from the current price of $253.07. The highest analyst price target is $213.57, and the lowest is $202.20.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ALNY Price Target
Average 221.72 (-12.39% Downside)
loading

Is Alnylam Pharmaceuticals Inc (ALNY) A Buy Now?

Oscillators
Name Value Action
RSI(14) 44.15 Neutral
STOCH(9,6) 61.48 Neutral
STOCHRSI(14) 71.46 Neutral
MACD(12,26) -7.1831 Buy
ADX(14) 17.67 Neutral
William %R -59.07 Neutral
CCI(14) 1.1464 Neutral
Buy: 1 Sell: 0 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
245.37
Buy
251.90
Buy
MA20
257.84
Sell
257.31
Sell
MA50
271.46
Sell
263.82
Sell
MA100
265.64
Sell
254.48
Sell
MA200
214.00
Buy
232.95
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, ALNY could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ALNY, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 44.15 indicates that ALNY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 61.48 indicates that ALNY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 71.46 indicates that ALNY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 17.67 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 1.1464 indicates that ALNY is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term ALNY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Alnylam Pharmaceuticals Inc financial reports and earnings history, Alnylam Pharmaceuticals Inc (ALNY) stock could reach $232.42 by 2030, $647.60 by 2040 and $800.34 by 2050. See the projected annual prices until 2050 of the Alnylam Pharmaceuticals Inc stock below:

  • Alnylam Pharmaceuticals Inc (ALNY) is expected to reach an average price of $474.82 in 2035, with a high prediction of $485.32 and a low estimate of $457.67. This indicates an $87.62% rise from the last recorded price of $253.07.
  • Alnylam Pharmaceuticals Inc (ALNY) stock is projected to chart a bullish course in 2040, with an average price target of $637.30, representing an $151.83% surge from its current level. The forecast ranges from a conservative $630.48 to a sky-high $647.60.
  • Our analysts predict Alnylam Pharmaceuticals Inc (ALNY) to jump 192.98% by 2045, soaring from $738.05 to an average price of $741.44, potentially reaching $762.93. While $738.05 is the low estimate, the potential upside is significant.
  • Alnylam Pharmaceuticals Inc (ALNY) stock is expected to climb by 2050, reaching an average of $799.16, a $215.78% jump from its current level. However, a wide range of estimates exists, with high and low targets of $800.34 and $780.11, respectively, highlighting the market's uncertainty.

Alnylam Pharmaceuticals Inc Stock (ALNY) Year by Year Forecast

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2025

Alnylam Pharmaceuticals Inc Stock (ALNY) is expected to reach an average price of $221.72 in 2025, with a high prediction of $266.11 and a low estimate of $177.33. This indicates an -12.39% fall from the last recorded price of $253.07.
Month Average Low High Change from today's price
January, 2025 $205.31 $202.20 $213.57 -18.87%
February, 2025 $205.09 $201.56 $212.45 -18.96%
March, 2025 $205.29 $198.06 $225.52 -18.88%
April, 2025 $200.93 $177.33 $226.91 -20.60%
May, 2025 $240.01 $191.54 $240.46 -5.16%
June, 2025 $234.85 $219.94 $247.12 -7.20%
July, 2025 $246.79 $216.79 $247.63 -2.48%
August, 2025 $260.45 $242.98 $262.29 +2.91%
September, 2025 $242.89 $240.86 $266.11 -4.02%
October, 2025 $223.65 $220.49 $243.55 -11.63%
November, 2025 $247.59 $221.35 $248.99 -2.17%
December, 2025 $226.42 $222.74 $251.60 -10.53%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2026

The predicted value for Alnylam Pharmaceuticals Inc (ALNY) in 2026 is set at an average of $275.72. Estimates vary from a peak of $326.01 to a trough of $225.44, indicating an +8.95% surge from the present price of $253.07.
Month Average Low High Change from today's price
January, 2026 $234.47 $225.44 $248.37 -7.35%
February, 2026 $248.27 $227.46 $248.39 -1.90%
March, 2026 $273.31 $230.65 $282.36 +8.00%
April, 2026 $263.46 $254.72 $285.94 +4.11%
May, 2026 $253.73 $242.08 $264.27 +0.26%
June, 2026 $248.97 $240.14 $256.73 -1.62%
July, 2026 $247.90 $237.28 $259.59 -2.04%
August, 2026 $278.38 $244.95 $278.69 +10.00%
September, 2026 $291.56 $268.25 $292.42 +15.21%
October, 2026 $311.22 $283.17 $315.90 +22.98%
November, 2026 $318.59 $309.27 $326.01 +25.89%
December, 2026 $307.65 $293.00 $320.22 +21.57%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Alnylam Pharmaceuticals Inc (ALNY) is $308.78, with a high forecast of $370.58 and a low forecast of $246.99. This indicates an +22.02% increase from the last price of $253.07.
Month Average Low High Change from today's price
January, 2027 $318.41 $305.46 $331.49 +25.82%
February, 2027 $301.95 $274.89 $322.82 +19.31%
March, 2027 $316.98 $291.33 $318.21 +25.25%
April, 2027 $272.07 $266.08 $322.58 +7.51%
May, 2027 $270.16 $249.16 $272.03 +6.75%
June, 2027 $290.64 $268.91 $293.87 +14.84%
July, 2027 $290.65 $275.78 $297.23 +14.85%
August, 2027 $295.53 $284.38 $308.01 +16.78%
September, 2027 $257.76 $246.99 $293.15 +1.85%
October, 2027 $268.25 $251.00 $272.41 +6.00%
November, 2027 $284.81 $266.66 $286.32 +12.54%
December, 2027 $367.63 $268.66 $370.58 +45.27%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2028

In 2028, Alnylam Pharmaceuticals Inc (ALNY) is projected to reach an average price of $350.91, with a high projection of $383.46 and a low estimate of $318.35. This indicates an +38.66% rise from the last price of $253.07.
Month Average Low High Change from today's price
January, 2028 $340.40 $339.09 $369.05 +34.51%
February, 2028 $336.28 $333.32 $363.29 +32.88%
March, 2028 $344.83 $318.35 $347.54 +36.26%
April, 2028 $351.46 $335.38 $361.33 +38.88%
May, 2028 $378.10 $342.56 $383.17 +49.41%
June, 2028 $371.02 $353.71 $383.46 +46.61%
July, 2028 $357.79 $355.24 $377.23 +41.38%
August, 2028 $326.65 $323.18 $370.73 +29.08%
September, 2028 $356.15 $325.06 $356.43 +40.73%
October, 2028 $358.37 $338.41 $358.79 +41.61%
November, 2028 $341.45 $330.20 $358.47 +34.92%
December, 2028 $338.89 $336.17 $353.62 +33.91%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2029

The 2029 price forecast for Alnylam Pharmaceuticals Inc Stock (ALNY) is $296.63 on average, with a high prediction of $368.71 and a low estimate of $224.55. This represents an +17.21% increase from the previous price of $253.07.
Month Average Low High Change from today's price
January, 2029 $345.81 $336.89 $368.71 +36.65%
February, 2029 $340.84 $329.92 $345.22 +34.68%
March, 2029 $337.73 $335.37 $364.82 +33.45%
April, 2029 $322.03 $313.38 $337.87 +27.25%
May, 2029 $317.26 $302.88 $328.37 +25.36%
June, 2029 $327.94 $312.76 $329.66 +29.59%
July, 2029 $349.11 $325.96 $355.70 +37.95%
August, 2029 $332.07 $331.53 $357.66 +31.22%
September, 2029 $317.98 $303.55 $335.80 +25.65%
October, 2029 $308.29 $305.44 $321.93 +21.82%
November, 2029 $307.36 $306.45 $322.00 +21.45%
December, 2029 $228.32 $224.55 $315.78 -9.78%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2030

Alnylam Pharmaceuticals Inc Stock (ALNY) is expected to reach an average price of $271.67 in 2030, with a high forecast of $319.57 and a low forecast of $223.78. This signifies an +7.35% surge from the last price of $253.07.
Month Average Low High Change from today's price
January, 2030 $229.82 $223.78 $232.42 -9.19%
February, 2030 $233.64 $229.99 $236.52 -7.68%
March, 2030 $238.12 $234.08 $242.62 -5.91%
April, 2030 $247.16 $234.15 $250.35 -2.34%
May, 2030 $249.62 $246.76 $256.37 -1.36%
June, 2030 $261.10 $243.46 $263.48 +3.17%
July, 2030 $281.71 $255.53 $287.24 +11.32%
August, 2030 $293.06 $286.12 $302.14 +15.80%
September, 2030 $299.09 $291.87 $300.44 +18.19%
October, 2030 $311.21 $291.59 $316.72 +22.97%
November, 2030 $282.29 $269.69 $316.58 +11.55%
December, 2030 $292.12 $275.86 $319.57 +15.43%
$616.55
price up icon 0.32%
$118.39
price down icon 1.93%
$215.00
price up icon 4.29%
$43.06
price down icon 0.76%
$370.49
price down icon 2.02%
Cap:     |  Volume (24h):